7/7/2021NMPA Re-elected as ICH Management Committee Member

7/7/2021Lippo Healthcare, AstraZeneca Pens Deal for Investment in China's Grea...

7/7/2021Neurolief Enters Licensing Deal with NeuroFront for Relivion in Greate...

7/7/2021dMed-Clinipace Completes US$50M Series C+ Financing

7/6/2021Alibaba Health-Backed LinkDoc Files for U.S. IPO

7/6/2021Antengene Granted Chinese IND Approval for Phase II Trial of Single-...

7/6/2021NMPA Announces Package Insert Revision of Metoclopramide Products

7/6/2021Innovent and Laekna Enter a Partnership to Co-Develop Combo of Sinti...

7/6/2021CStone Granted Chinese IND Approval for I/O Candidate CS2006/NM21-14...

7/6/2021Y-mAbs Submits Chinese BLA for DANYELZA® (naxitamab-gqgk)

7/5/2021GSK Launches HIV Drug Dovato (dolutegravir/lamivudine) in China

7/5/2021NMPA and CNIPA Issues the Implementation Measures for Early Resolution...

7/5/2021NMPA Issues Announcement Relating to the Implementation Measures for E...

7/5/2021Abbisko and Sperogenix Announce Deal of ABSK021 for ALS and Other Rare...

7/5/2021Nicox Amends Deal with Ocumension with $2M Upfront

7/5/2021Patent Linkage Implementing Measures Came Into Force in China on July ...

7/2/2021At A Glance: Pharmaceutical Merger Review in China

7/2/2021NDRC Issues the Implementation Plan for Infrastructural Building of th...

7/2/2021CDE Solicits Comments on the Requirements for Pharmaceutical Common Qu...

7/2/2021CDE Solicits Comments on the Requirements for Pharmaceutical Research ...

7/2/2021CDE Solicits Comments on the Guidelines for Clinical Value-Oriented Cl...

7/2/2021CDE Solicits Comments on the Guidelines for Clinical Studies of Crohn'...

7/1/2021ArriVent Raises $150M to Bring Chinese Drugs to Western Markets

6/30/2021BeiGene Wins Approval for $31B IPO at Shanghai's STAR Market

6/30/2021HUTCHMED Launches $325M Initial Public Offering in Hong Kong

6/30/2021Chinese Biotech/Healthcare Listings Help Elevate HK IPO Market To Thir...

6/30/2021NHSA Issues the Working Plan and the Application Guide for Adjustment ...

6/30/2021Recent Executive Moves

6/30/2021IQVIA: Potential of Chinese Pharma Lies in the Country's Huge Patient ...

6/30/2021IQVIA: Chinese Retail Pharmacy Sales Down 1.4% in Q1/2021

Page:195/789 Total number of articles:23668: [First][<<] [193] [194] [195] [196] [197] [>>] [End]